- Home
- SYBT vs HRMY Comparison
SYBT vs HRMY Comparison
Compare SYBT & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBT
- HRMY
- Stock Information
- Founded
- SYBT 1904
- HRMY 2017
- Country
- SYBT United States
- HRMY United States
- Employees
- SYBT N/A
- HRMY N/A
- Industry
- SYBT Major Banks
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- SYBT Finance
- HRMY Health Care
- Exchange
- SYBT Nasdaq
- HRMY Nasdaq
- Market Cap
- SYBT 2.0B
- HRMY 2.0B
- IPO Year
- SYBT N/A
- HRMY 2020
- Fundamental
- Price
- SYBT $73.12
- HRMY $39.05
- Analyst Decision
- SYBT Hold
- HRMY Strong Buy
- Analyst Count
- SYBT 4
- HRMY 8
- Target Price
- SYBT $65.25
- HRMY $55.00
- AVG Volume (30 Days)
- SYBT 171.3K
- HRMY 593.9K
- Earning Date
- SYBT 01-27-2025
- HRMY 02-20-2025
- Dividend Yield
- SYBT 1.67%
- HRMY N/A
- EPS Growth
- SYBT N/A
- HRMY N/A
- EPS
- SYBT 3.63
- HRMY 2.11
- Revenue
- SYBT $331,807,000.00
- HRMY $681,879,000.00
- Revenue This Year
- SYBT N/A
- HRMY $24.79
- Revenue Next Year
- SYBT $7.31
- HRMY $19.00
- P/E Ratio
- SYBT $20.14
- HRMY $18.55
- Revenue Growth
- SYBT 1.02
- HRMY 25.83
- 52 Week Low
- SYBT $42.35
- HRMY $28.14
- 52 Week High
- SYBT $79.79
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- SYBT 53.77
- HRMY 71.30
- Support Level
- SYBT $70.92
- HRMY $35.72
- Resistance Level
- SYBT $73.41
- HRMY $37.16
- Average True Range (ATR)
- SYBT 2.18
- HRMY 1.29
- MACD
- SYBT 0.26
- HRMY 0.48
- Stochastic Oscillator
- SYBT 96.18
- HRMY 92.25
About SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates a majority of its revenue from the Commercial Banking segment.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.